News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AHF: as Gilead Sciences, Inc. (GILD) Prepares to Price the "Quad," 20 California Legislators Say Aids Drug Pricing "Unsustainable"



8/20/2012 9:24:40 AM

SACRAMENTO, Calif.--(BUSINESS WIRE)--AIDS Healthcare Foundation today lauded California Assemblymember Betsy Butler (D, 53rd Assembly District) for a letter she wrote—and which nineteen fellow California state legislators cosigned—to Dr. Ron Chapman, Director of California’s Department of Public Health in which the legislators expressed concern about the rising costs of drugs to treat people with HIV/AIDS served by California’s AIDS Drug Assistance Program (ADAP) and encouraged Chapman’s department to, “…employ all the levers of influence and authority that the government possesses, independently and in partnership with other states, to reduce the price of prescription drugs used to treat HIV/AIDS and its co-morbidities.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES